Target intelligence / Profile preview

Redox pathways

Molecular classification
Other
01

Overview

Redox pathways refer to the complex networks regulating oxidation–reduction reactions in biological systems. These pathways coordinate the production and elimination of reactive species (like reactive oxygen species and reactive nitrogen species), control redox-sensitive signaling, and modulate enzyme and protein activity via reversible oxidation of key amino acid residues such as cysteine[1][2][3]. Major molecular players include enzymes (e.g., NADPH oxidases, superoxide dismutases, catalase, glutathione peroxidase), small molecule antioxidants (e.g., glutathione, ascorbate), and thiol redox switches in proteins. Redox homeostasis is central to normal cell function, including metabolism, differentiation, and response to environmental and physiological stimuli. Disruption of these pathways—either excess ROS production (oxidative stress) or inadequate signaling—can contribute to pathologies ranging from cancer and neurodegeneration to inflammation and metabolic syndromes. "Redox pathways" is a functional concept rather than a single protein or receptor, and thus, is not typically considered a direct molecular drug target[1][2][3].

Other names
redox signalingredox regulationredox systemsoxidative signalingredox homeostasis
02

Mechanism of action

Modulation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) production; Targeting redox-sensitive proteins (such as thiol switches); Induction or inhibition of antioxidant responses (e.g., NRF2 pathway activation); Direct scavenging of free radicals

03

Biological functions

Signal transductionMetabolismStress responseCell proliferationCell differentiationApoptosisImmune responseCell migrationRegulation of gene expressionRedox homeostasis
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationDiabetesInfectionAgingOther
05

Safety considerations

Broadly targeting redox pathways may affect both healthy and diseased tissue, disrupting normal physiological processes[2][3].Antioxidant therapies have shown limited or paradoxical effects in clinical settings[2].
06

Interacting drugs

antioxidants

2 more in the full profile.

07

Biomarkers

Levels of ROS (such as H₂O₂, superoxide)Glutathione (GSH/GSSG) ratioNADPH/NADP⁺ ratioProtein S-glutathionylation/S-nitrosylation

Beyond the preview

Go deeper on Redox pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Redox pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call